LEXICON PHARMACEUTICALS, INC. Interest Expense
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Interest Expense of $3.90 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2023-11-08
- LEXICON PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-09-30 was $3.90M, a 351.27% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-06-30 was $1.96M, a 178.81% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-03-31 was $1.82M, a 1555.45% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. interest expense for the quarter ending 2022-12-31 was $1.10M, a 273.90% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. interest expense for fiscal 2022 was $2.78M, a 246.63% increase from fiscal 2021.
- LEXICON PHARMACEUTICALS, INC. interest expense for fiscal 2021 was $802.00K, a 94.49% decline from fiscal 2020.
- LEXICON PHARMACEUTICALS, INC. interest expense for fiscal 2020 was $14.54M, a 29.66% decline from fiscal 2019.
- LEXICON PHARMACEUTICALS, INC. interest expense for fiscal 2019 was $20.68M, a 0.49% decline from fiscal 2018.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2023-09-30 | $3.90M 10-Q · filed 2023-11-08 | $5.86M derived: sum of 2 quarters · filed 2023-11-08 | $7.68M 10-Q · filed 2023-11-08 | $8.78M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2023-06-30 | $1.96M 10-Q · filed 2023-08-04 | $3.78M 10-Q · filed 2023-08-04 | $4.88M derived: sum of 3 quarters · filed 2023-08-04 | $5.75M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2023-03-31 | $1.82M 10-Q · filed 2023-05-04 | $2.92M derived: sum of 2 quarters · filed 2023-05-04 | $3.79M derived: sum of 3 quarters · filed 2023-11-08 | $4.49M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $1.97M derived: sum of 2 quarters · filed 2023-11-08 | $2.67M derived: sum of 3 quarters · filed 2023-11-08 | $2.78M 10-K · filed 2023-03-03 | |||
| 2022-09-30 | $864.00K 10-Q · filed 2023-11-08 | $1.57M derived: sum of 2 quarters · filed 2023-11-08 | $1.68M 10-Q · filed 2023-11-08 | $1.97M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $703.00K 10-Q · filed 2023-08-04 | $813.00K 10-Q · filed 2023-08-04 | $1.11M derived: sum of 3 quarters · filed 2023-08-04 | $1.28M derived: sum of 4 quarters · filed 2023-08-04 | |||
| 2022-03-31 | $110.00K 10-Q · filed 2023-05-04 | $405.00K derived: sum of 2 quarters · filed 2023-05-04 | $576.00K derived: sum of 3 quarters · filed 2023-05-04 | $745.00K derived: sum of 4 quarters · filed 2023-05-04 | |||
| 2021-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $466.00K derived: sum of 2 quarters · filed 2023-03-03 | $635.00K derived: sum of 3 quarters · filed 2023-03-03 | $802.00K 10-K · filed 2023-03-03 | |||
| 2021-09-30 | $171.00K 10-Q · filed 2022-11-09 | $340.00K derived: sum of 2 quarters · filed 2022-11-09 | $507.00K 10-Q · filed 2022-11-09 | $677.00K derived: sum of 4 quarters · filed 2023-03-03 | |||
| 2021-06-30 | $169.00K 10-Q · filed 2022-08-03 | $336.00K 10-Q · filed 2022-08-03 | $506.00K derived: sum of 3 quarters · filed 2023-03-03 | $4.62M derived: sum of 4 quarters · filed 2023-03-03 | |||
| 2021-03-31 | $167.00K 10-Q · filed 2022-05-05 | $337.00K derived: sum of 2 quarters · filed 2023-03-03 | $4.46M derived: sum of 3 quarters · filed 2023-03-03 | $9.58M derived: sum of 4 quarters · filed 2023-03-03 | |||
| 2020-12-31 | $170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $4.29M derived: sum of 2 quarters · filed 2023-03-03 | $9.41M derived: sum of 3 quarters · filed 2023-03-03 | $14.54M 10-K · filed 2023-03-03 | |||
| 2020-09-30 | $4.12M 10-Q · filed 2021-11-09 | $9.24M derived: sum of 2 quarters · filed 2021-11-09 | $14.37M 10-Q · filed 2021-11-09 | $19.57M derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2020-06-30 | $5.13M 10-Q · filed 2021-08-06 | $10.26M 10-Q · filed 2021-08-06 | $15.45M derived: sum of 3 quarters · filed 2022-03-10 | $20.65M derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2020-03-31 | $5.13M 10-Q · filed 2021-05-06 | $10.32M derived: sum of 2 quarters · filed 2022-03-10 | $15.53M derived: sum of 3 quarters · filed 2022-03-10 | $20.69M derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2019-12-31 | $5.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $10.39M derived: sum of 2 quarters · filed 2022-03-10 | $15.56M derived: sum of 3 quarters · filed 2022-03-10 | $20.68M 10-K · filed 2022-03-10 | |||
| 2019-09-30 | $5.20M 10-Q · filed 2020-10-30 | $10.37M derived: sum of 2 quarters · filed 2020-10-30 | $15.48M 10-Q · filed 2020-10-30 | $20.71M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2019-06-30 | $5.16M 10-Q · filed 2020-07-29 | $10.28M 10-Q · filed 2020-07-29 | $15.51M derived: sum of 3 quarters · filed 2021-03-12 | $20.76M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2019-03-31 | $5.12M 10-Q · filed 2020-04-27 | $10.34M derived: sum of 2 quarters · filed 2021-03-12 | $15.59M derived: sum of 3 quarters · filed 2021-03-12 | $20.78M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2018-12-31 | $5.22M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $10.48M derived: sum of 2 quarters · filed 2021-03-12 | $15.66M derived: sum of 3 quarters · filed 2021-03-12 | $20.78M 10-K · filed 2021-03-12 | |||
| 2018-09-30 | $5.25M 10-Q · filed 2019-11-07 | $10.44M derived: sum of 2 quarters · filed 2019-11-07 | $15.55M 10-Q · filed 2019-11-07 | $15.55M 10-Q · filed 2018-11-01 | $17.71M derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2018-06-30 | $5.19M 10-Q · filed 2019-08-01 | $10.30M 10-Q · filed 2019-08-01 | $10.30M 10-Q · filed 2018-07-30 | $12.46M derived: sum of 3 quarters · filed 2020-03-12 | $14.08M derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2018-03-31 | $5.11M 10-Q · filed 2019-05-01 | $5.11M 10-Q · filed 2018-05-03 | $7.28M derived: sum of 2 quarters · filed 2020-03-12 | $8.89M derived: sum of 3 quarters · filed 2020-03-12 | $10.51M derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2017-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $3.78M derived: sum of 2 quarters · filed 2020-03-12 | $5.40M derived: sum of 3 quarters · filed 2020-03-12 | $6.98M 10-K · filed 2020-03-12 | |||
| 2017-09-30 | $1.62M 10-Q · filed 2018-11-01 | $3.23M derived: sum of 2 quarters · filed 2018-11-01 | $4.82M 10-Q · filed 2018-11-01 | $6.46M derived: sum of 4 quarters · filed 2019-03-15 | |||
| 2017-06-30 | $1.61M 10-Q · filed 2018-07-30 | $3.20M 10-Q · filed 2018-07-30 | $4.84M derived: sum of 3 quarters · filed 2019-03-15 | $6.48M derived: sum of 4 quarters · filed 2019-03-15 | |||
| 2017-03-31 | $1.59M 10-Q · filed 2018-05-03 | $3.22M derived: sum of 2 quarters · filed 2019-03-15 | $4.87M derived: sum of 3 quarters · filed 2019-03-15 | $6.51M derived: sum of 4 quarters · filed 2019-03-15 | |||
| 2016-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $3.28M derived: sum of 2 quarters · filed 2019-03-15 | $4.92M derived: sum of 3 quarters · filed 2019-03-15 | $6.57M 10-K · filed 2019-03-15 | |||
| 2016-09-30 | $1.65M 10-Q · filed 2017-11-08 | $3.28M derived: sum of 2 quarters · filed 2017-11-08 | $4.93M 10-Q · filed 2017-11-08 | $6.61M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $1.64M 10-Q · filed 2017-08-01 | $3.29M 10-Q · filed 2017-08-01 | $4.96M derived: sum of 3 quarters · filed 2018-03-01 | $6.65M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $1.65M 10-Q · filed 2017-05-04 | $3.33M derived: sum of 2 quarters · filed 2018-03-01 | $5.01M derived: sum of 3 quarters · filed 2018-03-01 | $6.67M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $3.37M derived: sum of 2 quarters · filed 2018-03-01 | $5.02M derived: sum of 3 quarters · filed 2018-03-01 | $6.72M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $1.69M 10-Q · filed 2016-11-07 | $3.34M derived: sum of 2 quarters · filed 2016-11-07 | $5.04M 10-Q · filed 2016-11-07 | $5.94M derived: sum of 4 quarters · filed 2017-03-06 | |||
| 2015-06-30 | $1.66M 10-Q · filed 2016-08-04 | $3.36M 10-Q · filed 2016-08-04 | $4.25M derived: sum of 3 quarters · filed 2017-03-06 | $4.70M derived: sum of 4 quarters · filed 2017-03-06 | |||
| 2015-03-31 | $1.70M 10-Q · filed 2016-05-05 | $2.59M derived: sum of 2 quarters · filed 2017-03-06 | $3.04M derived: sum of 3 quarters · filed 2017-03-06 | $3.50M derived: sum of 4 quarters · filed 2017-03-06 | |||
| 2014-12-31 | $892.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $1.34M derived: sum of 2 quarters · filed 2017-03-06 | $1.80M derived: sum of 3 quarters · filed 2017-03-06 | $2.25M 10-K · filed 2017-03-06 | |||
| 2014-09-30 | $449.00K 10-Q · filed 2015-11-09 | $904.00K derived: sum of 2 quarters · filed 2015-11-09 | $1.36M 10-Q · filed 2015-11-09 | $1.84M derived: sum of 4 quarters · filed 2016-03-11 | |||
| 2014-06-30 | $455.00K 10-Q · filed 2015-08-07 | $912.00K 10-Q · filed 2015-08-07 | $1.39M derived: sum of 3 quarters · filed 2016-03-11 | $1.88M derived: sum of 4 quarters · filed 2016-03-11 | |||
| 2014-03-31 | $457.00K 10-Q · filed 2015-05-05 | $934.00K derived: sum of 2 quarters · filed 2016-03-11 | $1.43M derived: sum of 3 quarters · filed 2016-03-11 | $1.92M derived: sum of 4 quarters · filed 2016-03-11 | |||
| 2013-12-31 | $477.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $969.00K derived: sum of 2 quarters · filed 2016-03-11 | $1.47M derived: sum of 3 quarters · filed 2016-03-11 | $1.97M 10-K · filed 2016-03-11 | |||
| 2013-09-30 | $492.00K 10-Q · filed 2014-11-06 | $988.00K derived: sum of 2 quarters · filed 2014-11-06 | $1.49M 10-Q · filed 2014-11-06 | $2.01M derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2013-06-30 | $496.00K 10-Q · filed 2014-08-07 | $1.00M 10-Q · filed 2014-08-07 | $1.52M derived: sum of 3 quarters · filed 2015-03-12 | $2.05M derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2013-03-31 | $506.00K 10-Q · filed 2014-05-08 | $1.03M derived: sum of 2 quarters · filed 2015-03-12 | $1.55M derived: sum of 3 quarters · filed 2015-03-12 | $2.08M derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2012-12-31 | $520.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $1.05M derived: sum of 2 quarters · filed 2015-03-12 | $1.58M derived: sum of 3 quarters · filed 2015-03-12 | $2.11M 10-K · filed 2015-03-12 | |||
| 2012-09-30 | $527.00K 10-Q · filed 2013-11-12 | $1.06M derived: sum of 2 quarters · filed 2013-11-12 | $1.59M 10-Q · filed 2013-11-12 | $2.15M derived: sum of 4 quarters · filed 2014-03-07 | |||
| 2012-06-30 | $530.00K 10-Q · filed 2013-08-01 | $1.07M 10-Q · filed 2013-08-01 | $1.62M derived: sum of 3 quarters · filed 2014-03-07 | $2.18M derived: sum of 4 quarters · filed 2014-03-07 | |||
| 2012-03-31 | $537.00K 10-Q · filed 2013-05-10 | $1.09M derived: sum of 2 quarters · filed 2014-03-07 | $1.65M derived: sum of 3 quarters · filed 2014-03-07 | $2.46M derived: sum of 4 quarters · filed 2014-03-07 | |||
| 2011-12-31 | $551.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $1.11M derived: sum of 2 quarters · filed 2014-03-07 | $1.92M derived: sum of 3 quarters · filed 2014-03-07 | $2.53M 10-K · filed 2014-03-07 | |||
| 2011-09-30 | $560.00K 10-Q · filed 2012-11-07 | $1.37M derived: sum of 2 quarters · filed 2012-11-07 | $1.98M 10-Q · filed 2012-11-07 | $2.60M derived: sum of 4 quarters · filed 2013-03-11 | |||
| 2011-06-30 | $810.00K 10-Q · filed 2012-08-02 | $1.42M 10-Q · filed 2012-08-02 | $2.04M derived: sum of 3 quarters · filed 2013-03-11 | $2.68M derived: sum of 4 quarters · filed 2013-03-11 | |||
| 2011-03-31 | $607.00K 10-Q · filed 2012-05-03 | $1.23M derived: sum of 2 quarters · filed 2013-03-11 | $1.87M derived: sum of 3 quarters · filed 2013-03-11 | $2.60M derived: sum of 4 quarters · filed 2013-03-11 | |||
| 2010-12-31 | $626.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $1.26M derived: sum of 2 quarters · filed 2013-03-11 | $1.99M derived: sum of 3 quarters · filed 2013-03-11 | $2.72M 10-K · filed 2013-03-11 | |||
| 2010-09-30 | $637.00K 10-Q · filed 2011-11-01 | $1.37M derived: sum of 2 quarters · filed 2011-11-01 | $2.09M 10-Q · filed 2011-11-01 | ||||
| 2010-06-30 | $729.00K 10-Q · filed 2011-08-09 | $1.46M 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | $2.97M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |